placental tissue extract
Biologicalexperimental
Clinical trial activity
4 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
3
Phase 4
0
Earliest trial started Apr 1, 2013 (NCT01931748)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- melsmon
- placental tissue extract
- uncnt
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05363644 | Phase 3 | May 31, 2022 | Advent Health, Integra LifeSciences Corporation |
| NCT02379689 | N/A | Dec 1, 2014 | Semmes-Murphey Foundation |
| NCT02749695 | Phase 2/Phase 3 (Phase 3) | Oct 1, 2013 | Scientific Center for Family Health and Human Reproduction Problems, Russia |
| NCT01931748 | Phase 3 | Apr 1, 2013 | Unimed Pharmaceuticals |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Advent Health | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Integra LifeSciences Corporation | For profit | 1 | 0 | 1 | 2022 |
| Scientific Center for Family Health and Human Reproduction Problems, Russia | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Semmes-Murphey Foundation | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Unimed Pharmaceuticals | For profit | 1 | 1 | 1 | 2013 |
5 organizations
Page 1 / 1